Marketable securities held (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 9 Months Ended |
---|---|---|
Sep. 30, 2014
|
Sep. 30, 2014
|
|
Marketable Securities Held Details Narrative | ||
Exchange shares | 1,200,000 | |
Portion of shares in escrow | 260,000 | 600,000 |
Non-escrowed shares price per share | $ 10.00 | $ 10.00 |
Non-escrowed shares | 600,000 | |
Shares released | 90,000 | 90,000 |
Recognized loss on return of shares | $ 584 | $ 584 |
Fair value of released shares | 1,188 | 1,188 |
Unrealized gain | 604 | 604 |
Escrowed shares | 510,000 | 510,000 |
Claim made by MusclePharm | 3,037 | |
Musclepharm repurchase of shares | 2,500 | 2,500 |
Fair value of the Call Option | 363 | 363 |
Fair value of escrowed Musclepharm securities net | 3,042 | 3,042 |
Fair value of escrowed Musclepharm securities gross | $ 3,406 | $ 3,406 |
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Amount of third party guarantees against loss of value in the underlying assets related to available-for-sale security in an unrealized loss position and for which other-than-temporary impairments (OTTI) have not been recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
X | ||||||||||
- Definition
Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|